#USA #Chicago #Infectious Disease #Seegene #STAgora™

Seegene Unveils STAgora™: A Major Leap in Infectious Disease Analysis

In a remarkable advancement in the field of medical diagnostics, Seegene Inc., a global leader in molecular diagnostics, has officially launched the STAgora™ platform. This cutting-edge system is designed to revolutionize the analysis of infectious diseases by integrating real-time data analytics with AI-driven insights. Set to debut at the annual meeting of the Association for Diagnostics and Laboratory Medicine (ADLM) in Chicago, from July 27–31, 2025, STAgora™ aims to reshape how health authorities track and manage outbreaks worldwide.

Real-time Monitoring and Decision Support

The STAgora™ system stands out due to its ability to visualize real-time outbreak data across various regions, enabling clinicians to make informed decisions swiftly. By harnessing extensive databases of diagnostic test results, the platform provides healthcare professionals with organized reports and statistical analyses in user-friendly formats. This immediate access to actionable information is crucial for effective public health responses.

Health workers can monitor individual cases and observe epidemic trends in specified regions—be they local or international. This feature enhances situational awareness and allows for quick, data-driven actions in managing public health concerns. Ultimately, the aim is to equip both national and international health agencies with the necessary epidemiological data to enhance decision-making processes and develop effective responses to infectious disease outbreaks.

Advanced Statistical Tools for Early Detection

Equipped with over 40 statistical tools, STAgora™ facilitates the early detection of abnormal pathogen patterns while supporting predictive modeling for seasonal trends and emerging outbreaks. The system includes modules for monitoring infections, analyzing co-infections based on symptoms, and calculating real-time infection trend rates. Together, these capabilities transform static data into forward-looking insights, serving as a foundation for proactive health measures.

Unlike traditional disease outbreak monitoring systems that rely on retrospective data, STAgora™ performs real-time diagnostic analysis based on PCR test results. This innovative approach provides immediate insights into pathogen spread, while AI algorithms predict potential future disease outbreaks. According to Young-Seag Baeg, Seegene’s Director of Strategic Planning, the platform's unique architecture consolidates real-time diagnostic data from around the globe into a unified analytical system.

Integrating proprietary syndrome-based quantitative PCR technology, STAgora™ provides comprehensive insights into single pathogen infections as well as simultaneous multi-pathogen co-infections. This holistic diagnostics approach empowers healthcare providers to make quicker, more informed decisions at point-of-care settings.

The Importance of Timely Data in Modern Public Health

During the COVID-19 pandemic, the significance of timely and precise interpretation of diagnostic data became clear in shaping public health policies and treatment outcomes. As Daniel Shin, Seegene’s Executive Vice President and Global Sales and Marketing Director, states, the need for practical conclusions drawn from diagnostic data is foundational to clinical innovations and serves as a vital pillar of global health security. As challenges like antimicrobial resistance and viral mutations arise, swift insight into health data becomes increasingly essential.

The STAgora™ launch at the ADLM 2025 meeting will be a pivotal moment for Seegene. Beyond showcasing the platform's features, the event will mark the beginning of collaborations and partnerships with health leaders and clients worldwide. Seegene envisions STAgora™ as a cornerstone in building a smarter, faster, and more communicative global health system. By combining real-time molecular diagnostics with AI-based analysis, the platform represents a strategic step toward creating an intelligent public health infrastructure capable of proactive responses to emerging threats.

Building Resilience Against Infectious Diseases

With over 20 years of experience in research, development, and commercialization of real-time PCR technology for syndromic diagnostics, Seegene is well-prepared to address today's health challenges. The company's technology played a crucial role during the COVID-19 pandemic, delivering over 340 million COVID-19 tests to more than 100 countries worldwide. STAgora™ is seen as an evolution in diagnostic capabilities, providing greater insights into infectious diseases while enhancing readiness against future outbreaks.

Seegene’s continuous innovations also include CURECA™, a fully automated PCR system designed to minimize manual processes and facilitate real-time continuous testing. With capabilities to handle a wide array of sample types, CURECA™ offers scalable automation and flexible implementation, making it a valuable investment in both centralized and decentralized laboratories.

For more details, visit Seegene.com and follow them on LinkedIn.